|
|
||||||||
1Laboratory of Enteric Pathogens, Central Public Health Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency, 61 Colindale Avenue, London, NW9 5HT, UK 2Scottish Agricultural College, Veterinary Science Division, Drummondhill, Stratherrick Rd, Inverness, IV2 4JZ, UK 3Centre for Tropical and Veterinary Medicine, University of Edinburgh, Roslin, Midlothian, EH25 9RG, UK 4Centre for Molecular Microbiology and Immunology, Flowers Building, Imperial College, London, SW7 2AZ, UK
Correspondence C. Jenkins claire.jenkins{at}hpa.org.uk
Received July 29, 2003
Accepted July 29, 2003
Verocytotoxin-producing Escherichia coli (VTEC) causes a wide spectrum of disease in humans, from mild diarrhoea to haemolytic uraemic syndrome (HUS). The verocytotoxin (vtx) and intimin (eae) genes of VTEC strains, other than those of serogroup O157, were subtyped to identify common properties that may be associated with increased pathogenicity. Strains were isolated from patients with HUS, those with diarrhoea or from asymptomatic individuals. Strains of VTEC that carried vtx2 gene subtypes vtx2 and vtx2c were most commonly associated with HUS, whereas strains from patients with less severe disease and from the healthy control group were more likely to have vtx1c or vtx2d genes. The eae gene was detected more frequently in strains isolated from HUS patients than in those associated with cases of diarrhoea; ß-intimin was the most common intimin subtype in strains isolated from both groups of patients. None of the strains from the healthy control group carried the eae gene.
This article has been cited by other articles:
![]() |
M. G. Pedersen, C. Hansen, E. Riise, S. Persson, and K. E. P. Olsen Subtype-Specific Suppression of Shiga Toxin 2 Released from Escherichia coli upon Exposure to Protein Synthesis Inhibitors J. Clin. Microbiol., September 1, 2008; 46(9): 2987 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Persson, K. E. P. Olsen, S. Ethelberg, and F. Scheutz Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations J. Clin. Microbiol., June 1, 2007; 45(6): 2020 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Milnes, G. C. Pritchard, K. Sprigings, R. Futter, and G. A. Willshaw Verocytotoxin-producing E coli O26 infection in calves Vet Rec., July 29, 2006; 159(5): 159 - 159. [Full Text] [PDF] |
||||
![]() |
M. Noris and G. Remuzzi Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1035 - 1050. [Full Text] [PDF] |
||||
![]() |
C. Toma, E. Martinez Espinosa, T. Song, E. Miliwebsky, I. Chinen, S. Iyoda, M. Iwanaga, and M. Rivas Distribution of Putative Adhesins in Different Seropathotypes of Shiga Toxin-Producing Escherichia coli J. Clin. Microbiol., November 1, 2004; 42(11): 4937 - 4946. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mundy, C. Jenkins, J. Yu, H. Smith, and G. Frankel Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates J. Med. Microbiol., November 1, 2004; 53(11): 1145 - 1149. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |